Memory T-cell-specific therapeutics attenuate allograft rejection via mediation of alloreactivity in memory cells

Immunology Letters

Volumn 148, Issue 1, 2012, Pages 53-58

  Luo, Lei ^a   Sun, Zhaolin ^a   Cheng, Hui ^a   Luo, Guangheng ^a  

^a GUIZHOU PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Alloreactivity; Immunosuppressant; Memory T cell; Regulatory T cells; Tolerogenic dendritic cells

Indexed keywords

ALEFACEPT; BORTEZOMIB; CD2 ANTIGEN; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EFALIZUMAB; FINGOLIMOD; HERMES ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; T LYMPHOCYTE RECEPTOR; TACROLIMUS; TOFACITINIB;

ACUTE GRAFT REJECTION; ALLOIMMUNITY; CHIMERA; CHRONIC GRAFT REJECTION; CROSS REACTION; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DEPLETION; MEMORY CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE;

DENDRITIC CELLS; GRAFT REJECTION; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; ISOANTIGENS; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84865573450     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.08.001     Document Type: Review

References (80)

1. Andrew J.P., Mandy L.F., Allan D.K. Memory T-cell-specific therapeutics in organ transplantation. Curr Opin Organ Transplant 2009, 12:643-649.
2. McFarland R.D., Douek D.C., Koup R.A., Picker L.J. Identification of a human recent thymic emigraft phenotype. Proc Natl Acad Sci USA 2000, 97:4215-4220.
3. Ford M.L., Kirk A.D., Larsen C.P. Donor-reactive T-cell stimulation history and precursor frequency: barriers to tolerance induction. Transplantation 2009, 87:S69-S74.
4. Kaminski E.R., Hows J.M., Goldman J.M., Batchelor J.R. Lymphocytes from multi-transfused patients exhibit cytotoxicity against autologous cells. Br J Haematol 1992, 81(1):23-26.
5. van Kampen C.A., Versteeg-van der Voort Maarschalk M.F., Langerak-Langerak J., van Beelen E., Roelen D.L., Claas F.H. Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Hum Immunol 2001, 62(3):201-207.
6. Pelletier R.P., Hennessy P.K., Adams P.W., Orosz C.G. High incidence of donor-reactive delayed-type hypersensitivity reactivity in transplant patients. Am J Transplant 2002, 2(10):926-933.
7. Lombardi G., Sidhu S., Daly M., Batchelor J.R., Makgoba W., Lechler R.I. Are prime alloresponses truly primary?. Int Immunol 1990, 2(1):9-13.
8. Lechler R.I., Heaton T., Barber L., Bal V., Batchelor J.R., Lombardi G. Molecular mimicry by major histocompatibility complex molecules and peptides account for some alloresponses. Immunol Lett 1992, 34(1):63-69.
9. Valujskikh A., Baldwin W.M., Fairchild R.L. Recent progress and new perspectives in studying T cell responses to allografts. Am J Transplant 2010, 10(5):1117-1125.
10. Deacock S.J., Lechler R.I. Positive correlation of T cell sensitization with frequencies of alloreactive T helper cells in chronic renal failure patients. Transplantation 1992, 54(2):338-343.
11. Padovan E., Casorati G., Dellabona P., Giachino C., Lanzavecchia A. Dual receptor T-cell. Implications for alloreactivity and autoimmunity. Ann N Y Acad Sci 1995, 756:66-70.
12. Farber D.L. Biochemical signaling pathways for memory T cell recall. Semin Immunol 2009, 9:89-97.
13. Ford M.L., Larsen C.P. Overcoming the memory barrier in tolerance induction: molecular mimicry and functional heterogeneity among pathogen-specific T-cell populations. Curr Opin Organ Transplant 2010, 15(4):405-410.
14. Sourdive D.J., Murali-Krishna K., Altman J.D., Zajac A.J., Whitmire J.K., Pannetier C., et al. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J Exp Med 1998, 188(1):71-82.
15. + T-cell clones during primary human cytomegalovirus infection. Blood 2006, 108(9):3121-3127.
16. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401(6754):708-712.
17. + effector and memory T cell generation. Nat Immunol 2003, 4(9):835-842.
18. Goldrath A.W., Bogatzki L.Y., Bevan M.J. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med 2000, 192:557-564.
19. Kieper W.C., Jameson S.C. Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc Natl Acad Sci USA 1999, 96:13306-13311.
20. Ge Q., Hu H., Eisen H.N., Chen J.Z. Different contributions of thymopoiesis and homeostasis-driven proliferation to the reconstitution of naive and memory T cell compartments. Proc Natl Acad Sci USA 2002, 99:2989-2994.
21. Chang J.T., Palanivel V.R., Kinjyo I., Schambach F., Intlekofer A.M., Banerjee A., et al. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 2007, 315(5819):1687-1691.
22. Lohning M., Hegazy A.N., Pinschewer D.D., Busse D., Lang K.S., Hofer T., et al. Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors. J Exp Med 2008, 205(1):53-61.
23. Harrington L.E., Janowski K.M., Oliver J.R., Zajac A.J., Weaver C.T. Memory CD4 T cells emerge from effector T-cell progenitors. Nature 2008, 452(7185):356-360.
24. Moulton V.R., Bushar N.D., Leeser D.B., Patke D.S., Farber D.L. Divergent generation of heterogeneous memory CD4 T cells. J Immunol 2006, 177:869-876.
25. Preston E.H., Xu H., Dhanireddy K.K., Pearl J.P., Leopardi F.V., Starost M.F., et al. IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates. Am J Transplant 2005, 5:1032-1041.
26. Adams A.B., Pearson T.C., Larsen C.P. Heterologous immunity: an overlooked barrier to tolerance. Immunol Rev 2003, 196:147-160.
27. Brook M.O., Wood K.J., Jones N.D. The impact of memory T cells on rejection and the induction of tolerance. Transplantation 2006, 82:1-9.
28. Felix N.J., Allen P.M. Specificity of T-cell alloreactivity. Nat Rev Immunol 2007, 7:942-953.
29. Burrows S.R., Silins S.L., Moss D.J., Khanna R., Misko I.S., Argaet V.P. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J Exp Med 1995, 182:1703-1715.
30. Burrows S.R., Silins S.L., Khanna R., Burrows J.M., Rischmueller M., McCluskey J., et al. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur J Immunol 1997, 27:1726-1736.
31. Peter S.H., Neil S.G., Shannon K., Cora D., Donald E.H., James A.S., et al. Pretransplant frequency of donor-specific IFN-{gamma}-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999, 163:2267-2275.
32. Schenk A.D., Nozaki T., Rabant M., Valujskikh A., Fairchild R.L. Donor-reactive CD8 memory T cells infiltrate cardiac allografts within 24hours post-transplant in naive recipients. Am J Transplant 2008, 8(8):1652-1661.
33. Adams A.B., Williams M.A., Jones T.R., Shirasuqi N., Durham M.M., Kaech S.M., et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003, 111:1887-1895.
34. Koyama I., Nadazdin O., Boskovic S., Ochiai T., Smith R.N., Sykes M., et al. Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant 2007, 7(5):1055-1061.
35. Pearl J.P., Parris J., Hale D.A., Hoffmann S.C., Bernstein W.B., McCoy K.L., et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediate T-cell depletion. Am J Transplant 2005, 5:465-474.
36. + T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. J Immunol 2002, 169:4667-4673.
37. Chen Y., Heeger P.S., Valujskikh A. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J Immunol 2004, 172:5456-5466.
38. Kashizuka H., Sho M., Nomi T., Ikeda N., Kuzumoto Y., Akashi S., et al. Role of the ICOS-B7h costimulatory pathway in the pathophysiology of chronic allograft rejection. Transplantation 2005, 79:1045-1050.
39. Bemer V., Motta I., Perret R., Truffa-Bachi P. Interleukin-2 down-modulates memory T helper lymphocyte development during antigenic stimulation in vitro. Eur J Immunol 1995, 25:3394-3401.
40. Gupta M., Satyaraj E., Durdik J.M., Rath S., Bal V. Differential regulation of T cell activation for primary versus secondary proliferative responses. J Immunol 1997, 158:4113-4121.
41. Andrew J.P., Mandy L.F., Allan D.K. Memory T-cell-specific therapeutics in organ transplantation. Curr Opin Organ Transplant 2009, 14:643-649.
42. Michael P.H., Craig L.L. Alefacept for psoriasis. Semin Cutan Med Surg 2010, 29(1):53-55.
43. Weaver T.A., Charafeddine A.H., Agarwal A., Turner A.P., Russell M., Leopardi F.V., et al. Alefacept promotes costimulation blockade based allograft survival in nonhuman primates. Nat Med 2009, 15:746-749.
44. Shapira M.Y., Abdul-Hai A., Resnick I.B., Bitan M., Tsirigotis P., Gesundheit B., et al. Alefacept treatment for refractory chronic extensive GVHD. Bone Marrow Transplant 2009, 43:339-343.
45. Turner A.P., Weaver T., Badell R., Cano J., Avila J., Turner P., et al. LFA-3-Ig (Alefacept) prolongs allograft survival by targeting costimulation blockade resistant T effector memory cells in non-human primate islet transplantation. Am J Transplant 2009, 9(Suppl. 2):237.
46. Ford M., Wegener M., Cooper S., Kirk A., Larsen C. Overcoming the memory barrier: role of anti-LFA-1 in promoting long-term graft survival in recipients possessing donor-reactive memory T cells. Am J Transplant 2009, 9(Suppl. 2):536.
47. + memory cells early post-transplant. Am J Transplant 2009, 9(Suppl. 2):209.
48. Vincenti F., Mendez R., Pescovitz M., Rajagopalan P.R., Wilkinson A.H., Butt K., et al. A Phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti CD11a, anti-LFA-1 in renal transplantation. Am J Transplant 2007, 7:1770-1777.
49. Chiba K., Yanagawa Y., Masubuchi Y., Kataoka H., Kawaguchi T., Ohtsuki M., et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 1998, 160:5037-5044.
50. Chiba K., Hoshino Y., Suzuki C., Masubuchi Y., Yanagawa Y., Ohtsuki M., et al. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. Transplant Proc 1996, 28(2):1056-1059.
51. Hoshino Y., Suzuki C., Ohtsuki M., Masubuchi Y., Amano Y., Chiba K. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporin A. Transplant Proc 1996, 28(2):1060-1061.
52. Chiba K., Yanagawa Y., Masubuchi Y., Kataoka H., Kawaguchi T., Ohtsuki M., et al. FTY720, a novel immunosuppressant, induces the sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 1998, 160(10):5037-5044.
53. Kawaguchi T., Hoshino Y., Rahman F., Amano Y., Higashi H., Kataoka H., et al. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporin A. Transplant Proc 1996, 28:1062-1063.
54. Suzuki S., Enosawa S., Kakefuda T., Shinomiya T., Amari M., Naoe S., et al. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog. Transplantation 1996, 61(2):200-205.
55. Rochman Y., Spolski R., Leonard W.J. New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol 2009, 9(7):480-490.
56. Schluns K.S., Williams K., Ma A., Zheng X.X., Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol 2002, 168:4827-4831.
57. Borie D.C., Changelian P.S., Larson M.J., Si M.S., Paniagua R., Higgins J.P., et al. Immunosuppression by the JAK3 inhibitor CP-690, 550 delays rejection and significantly prolongs kidney allograft survival in nonhuman primates. Transplantation 2005, 79:791-801.
58. Changelian P.S., Flanagan M.E., Ball D.J., Kent C.R., Magnuson K.S., Martin W.H., et al. Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science 2003, 302:875-878.
59. Elliott P.J., Zollner T.M., Boehncke W.H. Proteasome inhibition: a new anti-inflammatory strategy. J Mol Med 2003, 81(4):235-245.
60. Blanco B., Perez-Simon J.A., Sanchez-Abarca L.I., Carvajal-Vergara X., Mateos J., Vidriales B., et al. Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines. Blood 2006, 107(9):3575-3583.
61. Kim J.S., Lee J.I., Shin J.Y., Kim S.Y., Shin J.S., Lim J.H., et al. Bortezomib can suppress activation of rapamycin-resistant memory T cells without affecting regulatory T-cell viability in nonhuman primates. Transplantation 2009, 88:1349-1359.
62. +T cells by alternatively activated dendritic cells. J Leukoc Biol 2008, 84:124-133.
63. Dong X., Bachman L.A., Kumar R., Griffin M.D. Generation of antigen-specific, interleukin-10-producing T-cells using dendritic cell stimulation and steroid hormone conditioning. Transpl Immunol 2003, 11:323-333.
64. Wang Z., Larregina A.T., Shufesky W.J., Perone M.J., Montecalvo A., Zahorchak A.F., et al. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am J Transplant 2006, 6:1297-1311.
65. Buckland M., Jago C.B., Fazekasova H., Scott K., Tan P.H., George A.J., et al. Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells. Am J Transplant 2006, 6:2046-2059.
66. Yates S.F., Paterson A.M., Nolan K.F., Cobbold S.P., Saunders N.J., Waldmann H., et al. Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation. J Immunol 2007, 179:967-976.
67. +T cells: markedly enhanced sensitivity of memory versus naive T cells to peripheral anergy. Cell Immunol 1993, 146:351-361.
68. Hayashi R.J., Loh D.Y., Kanagawa O., Wang F. Differences between responses of naive and activated T cells to anergy induction. J Immunol 1998, 160:33-38.
69. Andris F., Denanglaire S., de Mattia F., Urbain J., Leo O. Naïve T cells are resistant to anergy induction by anti-CD3 antibodies. J Immunol 2004, 173:3201-3208.
70. + T-cell populations. Am J Transplant 2006, 6:2580-2591.
71. + T cells. Cell Immunol 2012, 273:85-93.
72. +T-cell responses. Blood 2008, 111:2091-2100.
73. + memory T-cell responses. Eur J Immunol 2010, 40:2016-2025.
74. + LAG-31Foxp31CTLA-41 regulatory T cells that suppress allo-reactive memory T cells. Eur J Immunol 2011, 41:1663-1674.
75. + Treg cells correlate with transplant outcomes: a systematic review on recipients of solid organ transplantation. Cell Immunol 2011, 270:5-12.
76. Baan C.C., Velthuis J.H., van Gurp E.A., Mol W.M., Klepper M., Ijzermans J.N., et al. Functional CD25bright+ alloresponsive T cells in fully immunosuppressed renal allograft recipients. Clinical 2007, 21:63-71.
77. Hendrikx T.K., van Gurp E.A., Sewgobind V.D., Mol W.M., Schoordijk W., Klepper M., et al. Generation of donor-specific regulatory T-cell function in kidney transplant patients. Transplantation 2009, 87(3):376-383.
78. + regulatory T cells in operational tolerance after living donor liver transplantation. Transplant Proc 2005, 37:37-39.
79. + regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol 2004, 172:6539-6544.
80. Ge W., Jiang J., Liu W., Lian D., Saito A., Garcia B., et al. Regulatory T cells are critical to tolerance induction in presensitized mouse transplant recipients through targeting memory T cells. Am J Transplant 2010, 10(8):1760-1773.